Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation.

Xianyi Sha,Juan Wu,Yanzuo Chen,Xiaoling Fang
DOI: https://doi.org/10.2147/IJN.S28052
IF: 7.033
2012-01-01
International Journal of Nanomedicine
Abstract:The objective of our investigation was to design a self-microemulsifying drug-delivery system (SMEDDS) to improve the bioavailability of probucol. SMEDDS was composed of probucol, olive oil, Lauroglycol FCC, Cremophor EL, Tween-80, and PEG-400. Droplet sizes were determined. In vitro release was investigated. Pharmacokinetics and bioavailability of probucol suspension, oil solution, and SMEDDS were evaluated and compared in rats. Plasma drug concentration was determined by high-performance liquid chromatography. After administration of probucol suspension, plasma drug concentration was very low. Relative bioavailability of SMEDDS was dramatically enhanced in an average of 2.15- and 10.22-fold that of oil solution and suspension, respectively. It was concluded that bioavailability of probucol was enhanced greatly by SMEDDS. Improved solubility and lymphatic transport may contribute to the enhancement of bioavailability.
What problem does this paper attempt to address?